Skip to main content

Table 5 Change in SF-36 norm based Domain scores in refractory HCV patients re-treated with pegylated interferon alpha 2b and ribavirin: Responders versus non-responders

From: Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin

SF-36 domain Change from baseline at (responders minus non-responders)
  24 wks 48 wks 72 wks
Physical Function -3.26 -0.65 -0.32
Role-Physical -2.68 0.62 5.26
Bodily Pain 0.42 2.02 0.64
General Health -3.35 -0.85 2.91
Vitality -4.82 -3.89 3.64
Social Functioning -3.91 0.71 5.09
Role-Emotional -2.98 2.00 6.12
Mental Health -2.47 0.92 -0.48
Physical Component Score -2.65 -0.71 1.18
Mental Component Score -3.06 0.30 2.30
  1. None of the changes were statistically significant. Negative value suggest a worse score in responders